ArticleFrontiers in oncology2026

Immune checkpoint inhibitor-related myositis with hepatitis in HER2-positive metastatic breast cancer after trastuzumab deruxtecan plus sintilimab: a case report.

Ying Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.